Authors:
CLAUS JJ
DEKONING I
VANHARSKAMP F
BRETELER MMB
VOET B
GUTZMANN H
DAHLKE F
VANDERCAMMEN T
HOFMAN A
Citation: Jj. Claus et al., LISURIDE TREATMENT OF ALZHEIMERS-DISEASE - A PRELIMINARY PLACEBO-CONTROLLED CLINICAL-TRIAL OF SAFETY AND THERAPEUTIC EFFICACY, Clinical neuropharmacology, 21(3), 1998, pp. 190-195
Citation: T. Duka et al., THE EFFECTS OF A BENZODIAZEPINE RECEPTOR ANTAGONIST BETA-CARBOLINE ZK-93426 ON SCOPOLAMINE-INDUCED IMPAIRMENT ON ATTENTION, MEMORY AND PSYCHOMOTOR-SKILLS, Psychopharmacology, 123(4), 1996, pp. 361-373
Citation: T. Duka et al., SCOPOLAMINE AND LORAZEPAM EXERT DIFFERENT PATTERNS OF EFFECTS IN A TEST BATTERY ASSESSING STAGES OF INFORMATION-PROCESSING, Psychopharmacology, 119(3), 1995, pp. 315-324
Citation: Dn. Stephens et B. Voet, DIFFERENTIAL-EFFECTS OF ANXIOLYTIC AND NON-ANXIOLYTIC BENZODIAZEPINE RECEPTOR LIGANDS ON PERFORMANCE OF A DIFFERENTIAL REINFORCEMENT OF LOW-RATE (DRL) SCHEDULE, Behavioural pharmacology, 5(1), 1994, pp. 4-14
Authors:
PACCHETTI C
MARTIGNONI E
BRUGGI P
GODI L
AUFDEMBRINKE B
MILTENBURGER C
VOET B
NAPPI G
Citation: C. Pacchetti et al., TERGURIDE IN FLUCTUATING PARKINSONIAN-PATIENTS - A DOUBLE-BLIND-STUDYVERSUS PLACEBO, Movement disorders, 8(4), 1993, pp. 463-465